Related Experiment Video

Updated: Apr 5, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.8K

Enhancing the detection and management of acute hepatitis C virus infection

Marianne Martinello1, Gail V Matthews1

  • 1The Kirby Institute, University of New South Wales, Wallace Wurth Building, Sydney, NSW 2052, Australia.

The International Journal on Drug Policy
|August 10, 2015
PubMed

Insights

Detecting acute Hepatitis C virus (HCV) infection is challenging, especially in people who inject drugs (PWID). Improving detection and treatment access for acute HCV is crucial for preventing chronic liver disease.

Area of Science:

  • Hepatology and Viral Gastroenterology
  • Infectious Diseases and Public Health
  • Drug Use and Addiction Research

Background:

  • Acute Hepatitis C virus (HCV) infection, defined as the first 6 months post-acquisition, often presents asymptomatically or with non-specific symptoms.
  • While spontaneous clearance occurs in about 25% of cases, most individuals progress to chronic HCV infection, risking severe liver conditions like cirrhosis, end-stage liver disease, and hepatocellular carcinoma.
  • Identifying and managing acute HCV is difficult due to diagnostic limitations and challenges in reaching high-risk populations, notably people who inject drugs (PWID).

Purpose of the Study:

  • To review the challenges and opportunities in improving the detection and management of acute HCV infection.
  • To highlight the specific needs and barriers faced by people who inject drugs (PWID) in HCV assessment, treatment, and prevention.
  • To explore the potential of directly-acting antiviral (DAA) therapies for acute HCV infection, mirroring their success in chronic cases.

Main Methods:

  • Literature review focusing on the epidemiology, diagnosis, and treatment of acute HCV infection.
  • Analysis of barriers to HCV care within the PWID population.
  • Discussion of current and emerging therapeutic strategies, including DAAs, for acute HCV.

Main Results:

  • Detection of acute HCV remains suboptimal due to non-specific symptoms and diagnostic hurdles.
  • HCV treatment is feasible and effective in PWID, yet uptake is limited by individual and systemic barriers.
  • Directly-acting antiviral (DAA) therapies offer a promising avenue for effective acute HCV treatment, similar to their impact on chronic infections.

Conclusions:

  • Enhanced strategies for HCV assessment, treatment, and prevention are urgently needed, particularly for PWID.
  • Early detection and intervention during the acute phase of HCV infection can yield significant individual and public health benefits.
  • Leveraging highly effective DAAs for acute HCV management presents a critical opportunity to reduce the burden of HCV-related liver disease.

Keywords:
Acute hepatitis C virus infectionDirectly-acting antiviral (DAA)HIVInjecting drug use (IDU)Men-who-have-sex-with-men (MSM)People who inject drugs (PWID)Treatment

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

19.0K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
42
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
30
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
769
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.6K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
324
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
32